What is a cystic fibrosis diagnosis?Clin Chest Med 1998; 19(3):423-41, vCC
Abstract
Cystic fibrosis (CF) should be considered in patients with a wide variety of clinical presentations and of diverse racial and ethnic backgrounds. In most cases the diagnosis is suggested by manifestations of chronic sinopulmonary disease and exocrine pancreatic insufficiency, and then confirmed by a positive sweat test result. Patients may, however, present with pancreatic sufficiency or other atypical clinical features, sometimes in association with normal or borderline sweat test results. In such cases, the ability to detect CF mutations and to measure transepithelial bioelectric properties can be diagnostically useful. Mutation analysis can also be used for carrier screening, prenatal diagnosis, and newborn screening.
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
9759547
Citation
Rosenstein, B J.. "What Is a Cystic Fibrosis Diagnosis?" Clinics in Chest Medicine, vol. 19, no. 3, 1998, pp. 423-41, v.
Rosenstein BJ. What is a cystic fibrosis diagnosis? Clin Chest Med. 1998;19(3):423-41, v.
Rosenstein, B. J. (1998). What is a cystic fibrosis diagnosis? Clinics in Chest Medicine, 19(3), pp. 423-41, v.
Rosenstein BJ. What Is a Cystic Fibrosis Diagnosis. Clin Chest Med. 1998;19(3):423-41, v. PubMed PMID: 9759547.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - What is a cystic fibrosis diagnosis?
A1 - Rosenstein,B J,
PY - 1998/10/6/pubmed
PY - 1998/10/6/medline
PY - 1998/10/6/entrez
SP - 423-41, v
JF - Clinics in chest medicine
JO - Clin. Chest Med.
VL - 19
IS - 3
N2 - Cystic fibrosis (CF) should be considered in patients with a wide variety of clinical presentations and of diverse racial and ethnic backgrounds. In most cases the diagnosis is suggested by manifestations of chronic sinopulmonary disease and exocrine pancreatic insufficiency, and then confirmed by a positive sweat test result. Patients may, however, present with pancreatic sufficiency or other atypical clinical features, sometimes in association with normal or borderline sweat test results. In such cases, the ability to detect CF mutations and to measure transepithelial bioelectric properties can be diagnostically useful. Mutation analysis can also be used for carrier screening, prenatal diagnosis, and newborn screening.
SN - 0272-5231
UR - https://www.unboundmedicine.com/medline/citation/9759547/What_is_a_cystic_fibrosis_diagnosis
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0272-5231(05)70091-5
DB - PRIME
DP - Unbound Medicine
ER -